RN
REC Silicon ASA
RNWEF · OTC
$0.02 +0.00% (+$0.00)
Market Cap $8.20M
P/E Ratio -
Div. Yield -
ROE 15.08%
Bulios Fair Price
$0.02
0.0% downside
Current Price
$0.02
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RNWEF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.10x
P/E N/A
EV/EBITDA N/A
Growth
66 /100
Stable Rev. growth 4.94%
Book val. growth 9.00%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 45.84%
Net margin 80.59%
Op. margin 45.64%
Quality
65 /100
Average ROIC 9.98%
ROE 15.08%
ROA 44.61%
Debt
50 /100
Moderate Current ratio 0.08x
Int. coverage -0.93x
Net debt/EBITDA -3.29x
Stability
54 /100
Moderate Beta -0.11x
Rev. volatility 11.06%
EPS volatility 93.85%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RNWEF
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Kurt Levens
Employees
495
Headquarters
Lysaker